Clinicopathological features and outcomes of patients with gastric cancer: A single-center experience

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

444

HTML

3692

Figures (1-1)

316

Tables (1-5)

268

Sum=4720

Publishing Process of This Article

Item

Count

Browse

1278

Download

1280

Sum=2558

Apr 14, 2013 (publication date) through Feb 12, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Apr 14, 2013; 19(14): 2154-2161
Published online Apr 14, 2013. doi: 10.3748/wjg.v19.i14.2154

Table 2 Treatment received by the patients with gastric cancer (n = 796) n (%)

5-FU-LV: 5-Fluorouracil plus leucovorin; CF: Cisplatin-fluorouracil; DCF: Docetaxel-cisplatin-fluorouracil; ECF: Epirubicin-cisplatin-5FU.

Citation: Selcukbiricik F, Buyukunal E, Tural D, Ozguroglu M, Demirelli F, Serdengecti S. Clinicopathological features and outcomes of patients with gastric cancer: A single-center experience. World J Gastroenterol 2013; 19(14): 2154-2161
URL: https://www.wjgnet.com/1007-9327/full/v19/i14/2154.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i14.2154